Xavier Bertagna

24.8k total citations · 3 hit papers
262 papers, 14.5k citations indexed

About

Xavier Bertagna is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Xavier Bertagna has authored 262 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Endocrinology, Diabetes and Metabolism, 103 papers in Surgery and 60 papers in Cancer Research. Recurrent topics in Xavier Bertagna's work include Pituitary Gland Disorders and Treatments (113 papers), Adrenal and Paraganglionic Tumors (98 papers) and Cancer, Hypoxia, and Metabolism (58 papers). Xavier Bertagna is often cited by papers focused on Pituitary Gland Disorders and Treatments (113 papers), Adrenal and Paraganglionic Tumors (98 papers) and Cancer, Hypoxia, and Metabolism (58 papers). Xavier Bertagna collaborates with scholars based in France, United States and Italy. Xavier Bertagna's co-authors include Jérôme Bertherat, Lionel Groussin, John Newell‐Price, Ashley Grossman, Lynnette K. Nieman, Yves de Keyzer, Frédérique Tissier, Christine Gicquel, J P Luton and Joël Coste and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Xavier Bertagna

255 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

2003 963 citations Xavier Bertagna et al. The Journal of Clinical Endocrinology & Metabolism profile →
Cushing's syndrome

2006 837 citations Xavier Bertagna et al. profile →
Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane Therapy

1990 471 citations L Billaud, Xavier Bertagna et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xavier Bertagna France	64	8.6k	7.6k	4.0k	2.2k	1.4k	262	14.5k
Felix Beuschlein Germany	64	9.0k 1.0×	7.7k 1.0×	2.9k 0.7×	2.4k 1.1×	873 0.6×	428	13.5k
Jérôme Bertherat France	73	9.8k 1.1×	10.5k 1.4×	6.9k 1.7×	3.6k 1.6×	1.8k 1.2×	427	17.6k
Massimo Mannelli Italy	46	5.8k 0.7×	6.4k 0.8×	4.0k 1.0×	1.2k 0.5×	427 0.3×	215	9.0k
Philippe Chanson France	72	11.9k 1.4×	5.3k 0.7×	631 0.2×	2.7k 1.2×	1.5k 1.0×	396	16.7k
John Newell‐Price United Kingdom	47	10.5k 1.2×	5.6k 0.7×	810 0.2×	880 0.4×	589 0.4×	168	12.4k
Шломо Мелмед United States	94	23.1k 2.7×	7.5k 1.0×	2.9k 0.7×	6.7k 3.0×	3.4k 2.4×	477	31.2k
Henri Timmers Netherlands	45	3.8k 0.4×	4.5k 0.6×	2.9k 0.7×	592 0.3×	236 0.2×	151	6.4k
John P. Monson United Kingdom	53	6.9k 0.8×	2.2k 0.3×	485 0.1×	1.2k 0.5×	522 0.4×	189	8.7k
G. M. Besser United Kingdom	65	8.2k 0.9×	3.1k 0.4×	428 0.1×	1.4k 0.6×	746 0.5×	259	13.0k
Mitsuhide Naruse Japan	46	5.1k 0.6×	4.0k 0.5×	1.2k 0.3×	1.7k 0.8×	193 0.1×	261	9.1k

Countries citing papers authored by Xavier Bertagna

Since Specialization

Citations

This map shows the geographic impact of Xavier Bertagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Bertagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Bertagna more than expected).

Fields of papers citing papers by Xavier Bertagna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Bertagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Bertagna. The network helps show where Xavier Bertagna may publish in the future.

Co-authorship network of co-authors of Xavier Bertagna

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Bertagna. A scholar is included among the top collaborators of Xavier Bertagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Bertagna. Xavier Bertagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roucher‐Boulez, Florence, Dinane Samara‐Boustani, Pierre‐François Souchon, et al.. (2016). NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects. European Journal of Endocrinology. 175(1). 73–84. 54 indexed citations

Barreau, Olivia, Guillaume Assié, Bruno Ragazzon, et al.. (2012). Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 98(1). E174–E184. 90 indexed citations

Baudry, Camille, Joël Coste, S. Silvera, et al.. (2012). Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center. European Journal of Endocrinology. 167(4). 473–481. 135 indexed citations

Boddaert, Guillaume, et al.. (2012). Bronchial Carcinoid Tumors Causing Cushing's Syndrome: More Aggressive Behavior and the Need for Early Diagnosis. The Annals of Thoracic Surgery. 94(6). 1823–1829. 29 indexed citations

Gaujoux, Sébastien, Sophie Grabar, Martin Faßnacht, et al.. (2010). β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma. Clinical Cancer Research. 17(2). 328–336. 114 indexed citations

Donadille, Bruno, Lionel Groussin, Florence Tenenbaum, et al.. (2010). Management of Cushing’s Syndrome due to Ectopic Adrenocorticotropin Secretion with 1,Ortho-1, Para′-Dichloro-Diphenyl-Dichloro-Ethane: Findings in 23 Patients from a Single Center. The Journal of Clinical Endocrinology & Metabolism. 95(2). 537–544. 25 indexed citations

Ragazzon, Bruno, Rossella Libé, Sébastien Gaujoux, et al.. (2010). Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers. Cancer Research. 70(21). 8276–8281. 117 indexed citations

Coste, Joël, Frédérique Tissier, Lionel Groussin, et al.. (2010). Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis. European Journal of Endocrinology. 163(5). 793–800. 27 indexed citations

Libé, Rossella, Anélia Horvath, Amato Fratticci, et al.. (2010). Frequent phosphodiesterase 11a (pde11a4) gene mutations in patients with carney complex (cnc) due to prkar1a mutations and adrenal (ppnad) and Sertoli cell tumors (lccsct): a digenic disorder?. 22.

10.

Reyniès, Aurélien de, Guillaume Assié, David S. Rickman, et al.. (2009). Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival. Journal of Clinical Oncology. 27(7). 1108–1115. 278 indexed citations

11.

Groussin, Lionel, G. Bonardel, S. Silvera, et al.. (2009). 18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1713–1722. 138 indexed citations

12.

Carrasco, Carmen, Jöel Coste, Laurence Guignat, et al.. (2008). Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. 93(12). 4728–4734. 63 indexed citations

13.

Crémoux, Patricia de, Dan Rosenberg, J Goussard, et al.. (2008). Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocrine Related Cancer. 15(2). 465–474. 53 indexed citations

14.

Groussin, Lionel, Jérôme Bertherat, Christine Gicquel, Yves Le Bouc, & Xavier Bertagna. (2007). Insights into the Molecular Biology of Adrenocortical Tumors. Experimental and Clinical Endocrinology & Diabetes. 115(3). 175–178. 5 indexed citations

15.

Assié, Guillaume, Joël Coste, S. Silvera, et al.. (2006). Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 92(1). 172–179. 156 indexed citations

16.

Messager, Mathieu, Catherine Carrière, Xavier Bertagna, & Yves de Keyzer. (2005). RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome. European Journal of Endocrinology. 154(1). 159–166. 20 indexed citations

17.

Rosenberg, Dan, Lionel Groussin, Eric Jullian, et al.. (2002). Role of the PKA‐Regulated Transcription Factor CREB in Development and Tumorigenesis of Endocrine Tissues. Annals of the New York Academy of Sciences. 968(1). 65–74. 138 indexed citations

18.

Raffin‐Sanson, Marie‐Laure & Xavier Bertagna. (2000). Les multiples facettes de la proopiomélanocortine. 2(3). 243–250.

19.

Texier, Pascale, Yves de Keyzer, Roger Lacave, et al.. (1991). Proopiomelanocortin Gene Expression in Normal and Tumoral Human Lung*. The Journal of Clinical Endocrinology & Metabolism. 73(2). 414–420. 28 indexed citations

20.

Bertagna, Xavier, et al.. (1980). Sécrétion ectopique d’ACTH et de peptides apparentés (LPHs, β-endorphine, «16 K») Mise en évidence d’un précurseur commun. Hormone Research. 13(4-5). 291–301. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact